Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Cardiometabolic Considerations: The Role of LDL-C in ASCVD Risk Assessment & Insights into Optimal Management

Program Information

Program Information

ReachMD Healthcare Image

What’s the role of LDL-C in assessing a patient’s risk of atherosclerotic cardiovascular disease, and are statins the only recommended treatment option?

  • Overview

    Tune in to hear Dr. Norman Lepor from the UCLA Geffen School of Medicine discuss the role of LDL-C and comorbidities in atherosclerotic cardiovascular disease (ASCVD) risk assessment as well as the limitations of statin treatment.

    10/21     121913

Schedule20 Jan 2022
Webpack App